ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,943Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 103

$875K Total Retail Price of All Prescriptions

Rank: 6 out of 103

702 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 702 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 16,454 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 992 889 1 1
POTASSIUM CHLORIDE 704 654 2 10
FUROSEMIDE 702 654 3 4
OMEPRAZOLE 595 541 4 3
WARFARIN SODIUM 564 509 5 7
LISINOPRIL 400 336 6 5
HYDROCODONE-ACETAMINOPHEN 341 301 S3 7 11
SPIRONOLACTONE 337 322 8 30
METOPROLOL TARTRATE 325 316 9 9
SIMVASTATIN 319 287 10 2
LOSARTAN POTASSIUM 317 311 11 12
AMLODIPINE BESYLATE 317 295 11 6
FENTANYL 287 256 S2 13 34
ATORVASTATIN CALCIUM 284 260 14 18
DIGOXIN 280 262 15 25
TRAMADOL HCL 272 248 16 17
METOPROLOL SUCCINATE 271 247 17 8
ATENOLOL 267 234 18 14
ALENDRONATE SODIUM 267 239 18 19
TAMSULOSIN HCL 252 232 20 23
CITALOPRAM HBR 250 229 21 15
PRAVASTATIN SODIUM 242 225 22 33
NEXIUM 239 199 23 43
GLYBURIDE 236 193 R 24 76
CRESTOR 225 205 25 27
METHYLPREDNISOLONE 214 187 26 86
ZOLPIDEM TARTRATE 192 173 27 29
GABAPENTIN 171 126 28 22
LEVOFLOXACIN 164 140 29 57
SERTRALINE HCL 164 120 29 21
KLOR-CON 10 160 145 31 45
METFORMIN HCL 160 134 31 13
PANTOPRAZOLE SODIUM 160 144 31 95
MELOXICAM 156 142 34 49
TRIAMTERENE-HCTZ 151 135 35 38
AZITHROMYCIN 150 123 36 44
ALLOPURINOL 146 122 37 26
DONEPEZIL HCL 141 141 38 28
POLYETHYLENE GLYCOL 3350 131 96 39 31
ISOSORBIDE MONONITRATE ER 130 125 40 37
AMITRIPTYLINE HCL 122 96 R 41 54
LOSARTAN-HYDROCHLOROTHIAZIDE 117 111 42 47
ALBUTEROL SULFATE 113 83 43 68
GLYBURIDE-METFORMIN HCL 110 91 R 44 154
PREDNISONE 106 93 45 24
GEMFIBROZIL 103 81 46 62
CLOPIDOGREL 100 90 47 32
RANITIDINE HCL 97 85 48 53
HYDROCHLOROTHIAZIDE 95 84 49 16
SPIRIVA 95 80 49 64
CLONIDINE HCL 92 90 51 82
MIRTAZAPINE 92 81 51 36
FLUTICASONE PROPIONATE 91 86 53 35
ADVAIR DISKUS 90 89 54 42
CYMBALTA 86 47 55 60
SYNTHROID 85 85 56 51
PLAVIX 82 82 57 46
OXYCODONE HCL 81 42 S2 58 85
ENALAPRIL MALEATE 79 54 59 63
CARVEDILOL 79 77 59 20
CARBIDOPA-LEVODOPA 78 75 61 55
QUETIAPINE FUMARATE 73 66 62 84
TRIAMCINOLONE ACETONIDE 72 60 63 107
SINGULAIR 70 49 64 138
ESCITALOPRAM OXALATE 69 53 65 73
AVODART 68 53 66 115
FINASTERIDE 67 67 67 69
LANTUS 65 61 68 39
RAMIPRIL 63 63 69 126
FLUOXETINE HCL 63 35 69 92
PRAMIPEXOLE DIHYDROCHLORIDE 60 49 71 112
LIPITOR 56 51 72 127
GLIPIZIDE 54 48 73 65
DILTIAZEM 24HR CD 54 53 73 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 73 48
VERAPAMIL ER 53 53 76 91
ESTRADIOL 51 50 R 77 169
IPRATROPIUM BROMIDE 50 50 78 128
CEPHALEXIN 50 44 78 72
CIPROFLOXACIN HCL 50 45 78 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.